Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy

European Heart Journal

Volumn 29, Issue 17, 2008, Pages 2125-2132

  Knecht, Stefan ^a   Oelschläger, Christian ^a   Duning, Thomas ^a   Lohmann, Hubertus ^a   Albers, Johannes ^a   Stehling, Christoph ^a   Heindel, Walter ^a   Breithardt, Günter ^a   Berger, Klaus ^a   Ringelstein, E Bernd ^a   Kirchhof, Paulus ^a   Wersching, Heike ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Atrial fibrillation; Cognition, memory; Hippocampus, atrophy

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ARTICLE; ATTENTION; BLOOD CLOTTING; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN SIZE; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DEPTH PERCEPTION; DISEASE ASSOCIATION; EVALUATION RESEARCH; FEMALE; FUNCTIONAL ASSESSMENT; GERMANY; HEART ATRIUM FIBRILLATION; HIPPOCAMPUS; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; MICROEMBOLISM; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; STROKE; TASK PERFORMANCE; WHITE MATTER; WORKING MEMORY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATROPHY; CROSS-SECTIONAL STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; STROKE;

EID: 50849089302     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn341     Document Type: Article

References (56)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
2. Elias PK, Elias MF, Robbins MA, Budge MM. Blood pressure-related cognitive decline: does age make a difference? Hypertension 2004;44:631-636.
3. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005;4:752-759.
4. Sabatini T, Frisoni GB, Barbisoni P, Bellelli G, Rozzini R, Trabucchi M. Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc 2000;48:387-390.
5. Forti P, Maioli F, Pisacane N, Rietti E, Montesi F, Ravaglia G. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment. Neurol Res 2006;28:625-629.
6. Kilander L, Andren B, Nyman H, Lind L, Boberg M, Lithell H. Atrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly men. Stroke 1998;29:1816-1820.
7. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997;28:316-321.
8. Jozwiak A, Guzik P, Mathew A, Wykretowicz A, Wysocki H. Association of atrial fibrillation and focal neurologic deficits with impaired cognitive function in hospitalized patients >or = 65 years of age. Am J Cardiol 2006;98:1238-1241.
9. Tilvis RS, Kahonen-Vare MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 2004;59:268-274.
10. Elias MF, Sullivan LM, Elias PK, Vasan RS, D'Agostino RB Sr, Seshadri S, Au R, Wolf PA, Benjamin EJ. Atrial fibrillation is associated with lower cognitive performance in the framingham offspring men. J Stroke Cerebrovasc Dis 2006;15:214-222.
11. Inoue H, Nozawa T, Okumura K, Jong-Dae L, Shimizu A, Yano K. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism. Chest 2004;126:687- 692.
12. Barber M, Tait RC, Scott J, Rumley A, Lowe GD, Stott DJ. Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation. J Thromb Haemost 2004;2:1873-1878.
13. Kumral E, Balkir K, Uzuner N, Evyapan D, Nalbantgil S. Microembolic signal detection in patients with symptomatic and asymptomatic lone atrial fibrillation. Cerebrovasc Dis 2001;12:192-196.
14. Georgiadis D, Lindner A, Manz M, Sonntag M, Zunker P, Zerkowski HR, Borggrefe M. Intracranial microembolic signals in 500 patients with potential cardiac or carotid embolic source and in normal controls. Stroke 1997;28:1203-1207.
15. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992;327:1406-1412.
16. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-e354.
17. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GYH, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Euro Heart J 2007;28:2803-2817.
18. O'Connell JE, Gray CS, French JM, Robertson IH. Atrial fibrillation and cognitive function: case-control study. J Neurol Neurosurg Psychiatry 1998;65:386-389.
19. Farina E, Magni E, Ambrosini F, Manfredini R, Binda A, Sina C, Mariani C. Neuropsychological deficits in asymptomatic atrial fibrillation. Acta Neurol Scand 1997;96:310-316.
20. Park H, Hildreth A, Thomson R, O'Connell J. Non-valvular atrial fibrillation and cognitive decline: a longitudinal cohort study. Age Ageing 2007;36:157-163.
21. Rastas S, Verkkoniemi A, Polvikoski T, Juva K, Niinisto L, Mattila K, Lansimies E, Pirttila T, Sulkava R. Atrial fibrillation, stroke, and cognition: a longitudinal population-based study of people aged 85 and older. Stroke 2007;38:1454-1460.
22. Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke 2007;38:1766-1773.
23. Raz N, Rodrigue KM, Haacke EM. Brain aging and its modifiers: insights from in vivo neuromorphometry and susceptibility weighted imaging. Ann NY Acad Sci 2007;1097:84-93.
24. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
25. Hautzinger M, Bailer M, Worall H, Keller F. Beck-Depressions-Inventar (BDI). Göttingen: Hogrefe; 1995.
26. Knecht S, Wersching H, Lohmann H, Bruchmann M, Duning T, Dziewas R, Berger K, Ringelstein EB. High-normal blood pressure is associated with poor cognitive performance. Hypertension 2008;51:663-668.
27. Lezak MD. Neuropsychological Assessment. 4th ed. New York, Oxford: Oxford University Press; 2004.
28. Skullerud K. Variations in the size of the human brain. Influence of age, sex, body length, body mass index, alcoholism, Alzheimer changes, and cerebral atherosclerosis. Acta Neurol Scand Suppl 1985;102:1-94.
29. Jung DK, Devuyst G, Maeder P, Bogousslavsky J. Atrial fibrillation with small subcortical infarcts. J Neurol Neurosurg Psychiatry 2001;70:344-349.
30. Miyasaka Y, Barnes ME, Petersen RC, Cha SS, Bailey KR, Gersh BJ, Casaclang-Verzosa G, Abhayaratna WP, Seward JB, Iwasaka T, Tsang TS. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur Heart J 2007.
31. Forti P, Maioli F, Pisacane N, Rietti E, Montesi F, Ravaglia G. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI). Arch Gerontol Geriatr 2007;44(Suppl. 1):155-165.
32. Kato T, Yamashita T, Sagara K, Iinuma H, Fu LT. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ J 2004;68:568-572.
33. Breitenstein C, Jansen A, Deppe M, Foerster AF, Sommer J, Wolbers T, Knecht S. Hippocampus activity differentiates good from poor learners of a novel lexicon. Neuroimage 2005;25:958-968.
34. Choudhury A, Lip GY. Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb 2003;33:282-289.
35. Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 2003;107:3141-3145.
36. Hatzinikolaou-Kotsakou E, Kartasis Z, Tziakas D, Hotidis A, Stakos D, Tsatalas K, Bourikas G, Kotsakou ME, Hatseras DI. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations? J Thromb Thrombolysis 2003;16:155-161.
37. Zito M, Muscari A, Marini E, Di Iorio A, Puddu GM, Abate G. Silent lacunar infarcts in elderly patients with chronic non valvular atrial fibrillation. Aging (Milano) 1996;8:341-346.
38. Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H. Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 2005;45:1807-1812.
39. Tinkler K, Cullinane M, Kaposzta Z, Markus HS. Asymptomatic embolisation in non-valvular atrial fibrillation and its relationship to anticoagulation therapy. Eur J Ultrasound 2002;15:21-27.
40. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 2004;75:61-71.
41. Schmidt R, Petrovic K, Ropele S, Enzinger C, Fazekas F. Progression of leukoaraiosis and cognition. Stroke 2007;38:2619-2625.
42. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, Matthews PM, Fazekas F. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005;58:610-616.
43. Den Heijer T, Launer LJ, Prins ND, van Dijk EJ, Vermeer SE, Hofman A, Koudstaal PJ, Breteler MM. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 2005;64:263-267.
44. Korf ES, van Straaten EC, de Leeuw FE, van der Flier WM, Barkhof F, Pantoni L, Basile AM, Inzitari D, Erkinjuntti T, Wahlund LO, Rostrup E, Schmidt R, Fazekas F, Scheltens P. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med 2007;24:166-171.
45. Driscoll I, Hong NS, Craig LA, Sutherland RJ, McDonald RJ. Enhanced cell death and learning deficits after a mini-stroke in aged hippocampus. Neurobiol Aging 2007. Epub ahead of print.
46. Allen JS, Tranel D, Bruss J, Damasio H. Correlations between regional brain volumes and memory performance in anoxia. J Clin Exp Neuropsychol 2006;28:457-476.
47. Bigler ED, Anderson CV, Blatter DD. Temporal lobe morphology in normal aging and traumatic brain injury. Am J Neuroradiol 2002;23:255- 266.
48. Lupien SJ, Maheu F, Tu M, Fiocco A, Schramek TE. The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition. Brain Cogn 2007;65:209-237.
49. Valenzuela MJ, Sachdev P. Brain reserve and cognitive decline: a non-parametric systematic review. Psychol Med 2006;36:1065-1073.
50. Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, Moss M, Albert M. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol 2007;64:862-871.
51. Martinez-Martin P. [Impact of the cognitive impairment on the quality of life in patients with Parkinson's disease]. Rev Neurol 2006;43:168-172.
52. Nys GM, van Zandvoort MJ, van der Worp HB, de Haan EH, de Kort PL, Jansen BP, Kappelle LJ. Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke. J Neurol Sci 2006;247:149-156.
53. Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Vascular factors predict rate of progression in Alzheimer disease. Neurology 2007;69:1850-1858.
54. Snowdon DA. Healthy Aging and Dementia: Findings from the Nun Study. Ann Intern Med 2003;139:450-454.
55. DeKosky ST, Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science 2003;302:830-834.
56. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-1046.